Next Steps Unclear For Impax Following “Not Approvable” Letter On Vadova For Parkinson’s

FDA is concerned that the name Vadova may cause medication errors caused by confusing the drug with other marketed forms of carbidopa/levodopa.

More from Archive

More from Pink Sheet